GIL changes
Pick any two versions below to diff them.
- Checkpoints
- added: Oct 26, 2026: HanesBrands Australia sale closes and debt falls. Passed. Watch: Closing in the second half of 2026 with the cash used to repay term loans passes; a delay into 2027 or a lower price fails. Outcome: Gildan completed the sale on October 26, 2026, for about A$700 million in cash, and it said that it will use the net proceeds to repay debt. Nov 5, 2026: Q3 2026 results: sales against pro forma and the short seller's claim. Pending. Watch: Net sales near $1.65 billion with Wholesale and Retail both growing against pro forma sales pass; sales well below guidance or another fall against pro forma fails. removed: Dec 2026 (estimate): HanesBrands Australia sale closes and debt falls. Pending. Watch: Closing in the second half of 2026 with the cash used to repay term loans passes; a delay into 2027 or a lower price fails. Feb 2027 (estimate): Full-year 2026 results and 2027 outlook. Pending. Watch: Revenue of at least $6.0 billion, free cash flow near $1.0 billion and leverage that moves toward 2.5 times pass; missed guidance or higher leverage fails.
- Recent events
- Oct added: 26, 2026: Gildan completed the sale of HanesBrands Australia to BBFIT Investments, an entity of BB Retail Capital, for about A$700 million (about $490 million), paid in cash at closing. Gildan said that it will use the net proceeds to repay debt. Oct 8, 2026: The US Federal Trade Commission closed its investigation into Gildan and the distributor S&S under the Robinson-Patman Act. The investigation was about a contract clause that stopped Gildan from giving S&S's competitors the same prices and discounts. Gildan and S&S changed the clause. Gildan paid no penalty, made no settlement and admitted no wrongdoing. Jul 30, 2026: Gildan agreed to sell HanesBrands Australia to BBFIT Investments, an entity of BB Retail Capital, for an enterprise value of about A$700 million (about $490 million). It expects the sale to close in the second half of 2026, after regulatory approvals, and it will use the cash to reduce debt. Jul 30, 2026: Gildan reported Q2 2026 results. Net sales were $1.58 billion, up 72.3% because of HanesBrands, but lower than the pro forma $1.72 billion of a year earlier. Adjusted diluted EPS was $1.28, up 32.0%. Free cash flow was $326 million. Gildan raised its 2026 adjusted EPS guidance to $4.65 to $4.75 from $4.20 to $4.40, but it now expects revenue at the low end of $6.0 billion to $6.2 billion. Jul 30, 2026: Gildan said it expects about $220 million of refunds of IEEPA tariffs in 2026, after the US Supreme Court ruled against these tariffs on February 20, 2026. It recorded about $25 million in Q2 and expects most of the rest in Q3. Tariffs no longer apply to clothing that qualifies under the CAFTA-DR trade agreement, and this gives a lasting cost benefit. Jun 16, 2026: The short seller Jehoshaphat Research alleged that Gildan pushed too much stock into its distribution channel to make revenue grow. Gildan said its disclosure is accurate and kept its 2026 guidance. The stock fell 18.8% that day, to $50.35 on the NYSE. Law firms later started to look for shareholders for possible securities claims. Apr 30, 2026: Gildan reported Q1 2026 results, the first full quarter with HanesBrands. Net sales were $1.17 billion, up 63.8%, but lower than the pro forma $1.29 billion of a year earlier, because Gildan reduced inventory at its customers. Adjusted diluted EPS was $0.43. Gildan kept its 2026 guidance.